FibroGen Inc FGEN:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 6:03 PM EDT
21.10quote price arrow down-0.02 (-0.09%)
Volume
24,006
Close
21.12quote price arrow up+0.06 (+0.28%)
Volume
1,369,610
52 week range
18.12 - 57.21

...

Loading . . .
  • Open21.04
  • Day High21.65
  • Day Low20.51
  • Prev Close21.06
  • 52 Week High57.21
  • 52 Week High Date02/12/21
  • 52 Week Low18.12
  • 52 Week Low Date04/09/21

Key Stats

  • Market Cap1,944.52M
  • Shares Out92.07M
  • 10 Day Average Volume3.02M
  • Dividend-
  • Dividend Yield-
  • Beta1.01
  • YTD % Change-43.06

KEY STATS

  • Open21.04
  • Day High21.65
  • Day Low20.51
  • Prev Close21.06
  • 52 Week High57.21
  • 52 Week High Date02/12/21
  • 52 Week Low18.12
  • 52 Week Low Date04/09/21
  • Market Cap1,944.52M
  • Shares Out92.07M
  • 10 Day Average Volume3.02M
  • Dividend-
  • Dividend Yield-
  • Beta1.01
  • YTD % Change-43.06

RATIOS/PROFITABILITY

  • EPS (TTM)-2.13
  • P/E (TTM)-9.90
  • Fwd P/E (NTM)-14.90
  • EBITDA (MRQ)-169.83M
  • ROE (MRQ)-40.35%
  • Revenue (MRQ)176.32M
  • Gross Margin (MRQ)94.97%
  • Net Margin (MRQ)-107.36%
  • Debt To Equity (MRQ)13.36%

EVENTS

  • Earnings Date05/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From FibroGen Inc

There is no recent news for this security.

Profile

MORE
FibroGen, Inc. is a biopharmaceutical company committed to discovering, developing and commercializing a pipeline of first-in-class therapeutics. The Company applies its capabilities in hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF) biology to advance innovative medicines for the treatment of unmet needs. The Company is currently developing and commercializing roxadustat, an oral small molecule inhibitor of HIF prolyl hydroxylase activity, for...
James Schoeneck
Chairman
Enrique Conterno
Chief Executive Officer
Pat Cotroneo
Chief Financial Officer
Address
409 Illinois St
San Francisco, CA
94158-2509
United States

Top Peers

SYMBOLLASTCHG%CHG
DRNA
Dicerna Pharmaceuticals Inc
28.86-0.52-1.77%
MGNX
MacroGenics Inc
33.66-0.04-0.12%
BLUE
bluebird bio Inc
28.78+0.66+2.35%
SGMO
Sangamo Therapeutics Inc
11.85-0.02-0.17%
LGND
Ligand Pharmaceuticals Inc
147.98-4.12-2.71%